Market
OncoSil Medical secures funding for cancer device launch
OncoSil Medical has secured A$5.6 million ($4.03 million) in funding commitments to support the launch of its single-use brachytherapy device for cancer treatment. The capital raise will enable commercialization of the device.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network